By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

BioMarker Strategies 

606 Baltimore Avenue
Suite 402
Baltimore  Maryland  21204  U.S.A.
Phone: 410-532-2641 Fax: 410-532-6606


SEARCH JOBS








Company News
BioMarker Strategies Announces Phase II NCI Grant To Continue Development Of Companion Diagnostic Test To Help Select Optimal Therapy For Patients With Non-Small Cell Lung Cancer 9/11/2017 8:16:04 AM
BioMarker Strategies Announces Two New Patents Granted In Japan, Covering The Company’s Core Diagnostics Technologies For Solid Tumor Cancers 9/1/2017 8:09:23 AM
BioMarker Strategies Announces Issuance Of Key Patent In Europe Covering The Company’s Pathmap Functional Signaling Profile Technology 7/19/2017 10:44:12 AM
BioMarker Strategies Awarded Phase I NCI Contract To Develop Novel Predictive Test For Response To Immunotherapies For Patients With Non-Small Cell Lung Cancer 9/19/2016 11:11:25 AM
BioMarker Strategies Awarded Phase I/II Fast Track National Cancer Institute Grant To Develop Companion Diagnostic Test To Select Optimal Therapy For Patients With Non-Small Cell Lung Cancer 6/30/2016 9:25:22 AM
BioMarker Strategies Announces Issuance Of Key Patents In The United States, Europe, Australia And Hong Kong 1/7/2016 10:59:07 AM
BioMarker Strategies Names Jerry Parrott President and Chief Executive Officer 10/1/2013 10:44:41 AM
BioMarker Strategies Awarded $1.5 Million National Cancer Institute Contract to Develop Companion Diagnostic Test to Select Optimal Therapy for Melanoma Patients 9/25/2013 9:43:04 AM
BioMarker Strategies Names Jack Davis as Executive Chairman 10/3/2012 9:56:59 AM
BioMarker Strategies Appoints Glenn Miller to Board of Directors as Chairman 5/31/2011 9:30:18 AM
12
//-->